Christopher R. Fenimore, Executive Vice President Finance and CFO of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), filed a Form 4 on August 20, 2026, disclosing transactions in common stock and a non-qualified stock option dated August 18, 2026.
Jeffrey A. Bertelsen, Chief Financial Officer of Rigetti Computing, Inc., filed a Form 4 on August 20, 2026, reporting a nondiscretionary sale of common stock to satisfy tax withholding obligations connected to the settlement of restricted stock units.
Bitcoin traded near USD 72,837 on Thursday, up 6.57% on the day, marking its highest level since early June and extending a two-day gain of roughly 12%. The rally has been driven by several converging catalysts rather than a single trigger. The Treasury Department's …
Bruno Sousa Mauad, a director at Aura Minerals Inc. (NASDAQ:AUGO), filed a Form 4 on August 20, 2026, disclosing the sale of 280,000 common shares and 38,684 Brazilian Depositary Receipts on August 19, 2026, held indirectly through Kapitalo Investimentos.
Anna M. Alvarado, Chief Legal Officer of Texas Capital Bancshares Inc/TX (NASDAQ:TCBI), filed a Form 4 on August 20, 2026, reporting a disposition of 51 shares of common stock on August 19, 2026.
Jason W. Vasquez, VP-Sales & Marketing-USSC at Applied Industrial Technologies Inc, filed a Form 4 on August 20, 2026, reporting transactions in common stock and stock appreciation rights dated August 18, 2026.
David K. Wells, Vice President, CFO and Treasurer of Applied Industrial Technologies Inc, filed a Form 4 on August 20, 2026, reporting the sale of 1,812 shares of common stock on August 18, 2026.
Director Nancy C. Andrews filed a Form 4 with the SEC on August 20, 2026, reporting transactions in Charles River Laboratories International, Inc. common stock that occurred on August 18, 2026.
Shannon M. Parisotto, Chief Executive Vice President of Discovery and Safety Assessment at Charles River Laboratories International, Inc., filed a Form 4 on August 20, 2026, disclosing a same-day stock option exercise and share sale on August 19, 2026, conducted under a pre-established Rule …
Birgit Girshick, Chief Executive Officer and Director of Charles River Laboratories International, Inc., filed a Form 4 on August 20, 2026, reporting a disposition of 528 shares of common stock on August 19, 2026, via a gift transaction at a price of $0.